The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer

被引：0
|
作者：
Ching-Wen Huang
Hsiang-Lin Tsai
Yi-Ting Chen
Chun-Ming Huang
Cheng-Jen Ma
Chien-Yu Lu
Chao-Hung Kuo
Deng-Chyang Wu
Chee-Yin Chai
Jaw-Yuan Wang
机构：
[1] Kaohsiung Medical University,Graduate Institute of Medicine, College of Medicine
[2] Kaohsiung Medical University,Department of Surgery, Kaohsiung Municipal Hsiao
[3] Kaohsiung Medical University Hospital,Kang Hospital
[4] Kaohsiung Medical University,Division of Gastrointestinal and General Surgery, Department of Surgery
[5] Kaohsiung Medical University,Cancer Center, Kaohsiung Medical University Hospital
[6] Kaohsiung Medical University Hospital,Division of General Surgery Medicine, Department of Surgery
[7] Fooyin University,Program of Bachelor of Health Beauty, School of Medical and Health Sciences
[8] Kaohsiung Medical University,Department of Pathology, Kaohsiung Medical University Hospital
[9] Kaohsiung Medical University Hospital,Department of Radiation Oncology
[10] Kaohsiung Medical University,Graduate Institute of Clinical Medicine, College of Medicine
[11] Kaohsiung Medical University Hospital,Division of Gastroenterology, Department of Internal Medicine
[12] Kaohsiung Medical University,Department of Internal Medicine, Faculty of Medicine, College of Medicine
[13] Kaohsiung Medical University,Department of Pathology, Faculty of Medicine, College of Medicine
[14] Kaohsiung Medical University,Department of Surgery, Faculty of Medicine, College of Medicine
[15] Kaohsiung Medical University,undefined
来源：
BMC Cancer | / 13卷
关键词：
Epidermal growth factor receptor; Prognostic value; Metachronous; Synchronous; Metastatic colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
    Huang, Ching-Wen
    Tsai, Hsiang-Lin
    Chen, Yi-Ting
    Huang, Chun-Ming
    Ma, Cheng-Jen
    Lu, Chien-Yu
    Kuo, Chao-Hung
    Wu, Deng-Chyang
    Chai, Chee-Yin
    Wang, Jaw-Yuan
    [J]. BMC CANCER, 2013, 13
  • [2] Influence of KRAS Mutation Status in Metachronous and Synchronous Metastatic Colorectal Adenocarcinoma
    Rose, Jeffrey S.
    Serna, Derek S.
    Martin, Ludmila Katherine
    Li, Xiaobai
    Weatherby, Lynn M.
    Abdel-Misih, Sherif
    Zhao, Weiqiang
    Bekaii-Saab, Tanios
    [J]. CANCER, 2012, 118 (24) : 6243 - 6252
  • [3] Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinomas
    Serna, D. S.
    Martin, L. K.
    Li, X.
    Weatherby, L. M.
    Rose, J. S.
    Bekaii-Saab, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [4] An analysis of prognostic factors in patients with synchronous and metachronous metastatic colorectal cancer
    Tei, Mitsuyoshi
    Ohtsuka, Masahisa
    Suzuki, Yozo
    Kishi, Kentaro
    Tanemura, Masahiro
    Akamatsu, Hiroki
    [J]. CANCER SCIENCE, 2018, 109 : 1358 - 1358
  • [5] Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients
    Vincenzi, B.
    Cremolini, C.
    Sartore-Bianchi, A.
    Russo, A.
    Mannavola, F.
    Perrone, G.
    Pantano, F.
    Loupakis, F.
    Rossini, D.
    Ongaro, E.
    Bonazzina, E.
    Zoccoli, A.
    De Maglio, G.
    Fontanini, G.
    Falcone, A.
    Santini, D.
    Onetti-Muda, A.
    Siena, S.
    Tonini, G.
    Aprile, G.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 38 - 38
  • [6] PROGNOSTIC IMPLICATIONS OF SYNCHRONOUS AND METACHRONOUS ADENOMAS IN PATIENTS WITH COLORECTAL CANCER
    Patel, A.
    Spector, E.
    Ranat, R.
    Ali, O.
    Williams, N.
    Arasaradnam, R.
    [J]. GUT, 2016, 65 : A182 - A183
  • [7] Prognostic significance of KRAS mutation rate in metastatic colorectal cancer (mCRC) patients (pts).
    Vincenzi, Bruno
    Loupakis, Fotios
    Bianchi, Andrea Sartore
    Russo, Antonio
    Mannavola, Francesco
    Perrone, Giuseppe
    Cremolini, Chiara
    Rossini, Daniele
    Ongaro, Elena
    Bonazzina, Erica
    Dell'Aquila, Emanuela
    Imperatori, Marco
    De Maglio, Giovanna
    Falcone, Alfredo
    Santini, Daniele
    Onetti-Muda, Andrea
    Siena, Salvatore
    Aprile, Giuseppe
    Tonini, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Influence of KRAS mutation on prognostic impact of systemic inflammation in metastatic colorectal cancer patients
    Miyamoto, Yuji
    Hiyoshi, Yukiharu
    Daitoku, Nobuya
    Sakamoto, Yuki
    Kiyozumi, Yuki
    Eto, Kojiro
    Iwagami, Shiro
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Yoshida, Naoya
    Baba, Hideo
    [J]. CANCER SCIENCE, 2018, 109 : 1357 - 1357
  • [9] Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
    Ucar, Gokhan
    Ergun, Yakup
    Esen, Selin Akturk
    Acikgoz, Yusuf
    Dirikoc, Merve
    Esen, Irfan
    Bal, Oznur
    Uncu, Dogan
    [J]. MEDICINE, 2020, 99 (39) : E22407
  • [10] KRAS Mutation is a Poor Prognostic Factor in Patients undergoing Hepatic Resection for Metastatic Colorectal Cancer
    Aufforth, R. D.
    Baker, J. J.
    Auman, J.
    Eil, R.
    McLeod, H.
    Kim, H.
    Meyers, M. O.
    Calvo, B. F.
    Yeh, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S94 - S95
12345